Greenwich LifeSciences, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -52.26 | -100% |
| P/S |
|
0 | 33.58 | -100% |
|
|
| P/BV |
|
21.32 | 4.79 | 344.94% |
|
|
| P/FCF |
|
0 | 60.06 | -100% |
|
|
| Ev/Ebitda |
|
-14.57 | -17.26 | -15.57% |
|
|
| Ev/S |
|
0 | 22.49 | -100% |
|
|
| Ev/FCF |
|
-20.97 | 67.63 | -131.01% |
|
|
| E/P |
|
0 | 0.0168 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.5 | -100% | 0 | 0% |
| ROE |
|
-132.71 | 9.39 | -1513.06% |
|
|
| ROA |
|
-127.12 | 0.1519 | -83773.09% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.64 | -100% |
|
|
| ROCE |
|
-139.21 | 15.19 | -1016.72% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | -3.68 | -100% | -6.7E-5 | -100% |
| Nеt Debt/Ebitda |
|
0.7496 | -4.07 | -118.43% |
|
|
| Debt/Ratio |
|
0 | 0.199 | -100% |
|
|
| Debt/Equity |
|
0 | 1.67 | -100% |
|
|
| Debt/Net Income |
|
0 | 10.34 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 76.2 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
174.24 | 44.75 | 289.36% | ||
| Growth impulse Net Income in 5 years |
|
161.52 | -15.36 | -1151.56% | ||
| Growth impulse FCF in 5 years |
|
2111.13 | -9.39 | -22582.75% | ||
| Growth impulse EPS in 5 years |
|
141.81 | -84.03 | -268.76% |
IP Score
3.89/10
